Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycerol-3-phosphate dehydrogenase 2 (mitochondrial), pseudogene (ENSG00000266907) is a **nonfunctional segment of DNA** homologous to the gene encoding the mitochondrial enzyme glycerol-3-phosphate dehydrogenase 2 (GPD2). Pseudogenes, such as this, result from gene duplication or retrotransposition events and *lack the regulatory sequences or coding integrity required to produce a functional protein product*. They are classified as "junk DNA" and are generally not involved in cellular metabolism, disease, or therapeutic targeting. While rare pseudogenes may have regulatory roles or create noncoding RNAs, there is no evidence this pseudogene is biologically active or relevant for drug targeting or diagnostic purposes[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycerol-3-phosphate dehydrogenase 2 (mitochondrial), pseudogene.